Overview
Description
Organon & Co. is a global healthcare company that focuses on providing vital medicines and products to improve the well-being of women around the world. Primarily functioning within the pharmaceutical and biotechnology sectors, Organon has a strong portfolio that addresses a wide range of health needs. The company is particularly prominent in the production and enhancement of women's health products, focusing on contraception, fertility solutions, and other gynecological therapies. Beyond women’s health, it also offers solutions in biosimilars and established brands across various therapeutic areas. Organon emerged as a standalone company after its spin-off from Merck & Co., with the aim of concentrating on traditionally underserved areas in healthcare. Through its innovative approach and specialized focus, Organon plays a pivotal role in addressing global health disparities, delivering essential healthcare solutions, and contributing significantly to the broader pharmaceutical industry landscape.
About
CEO
Mr. Kevin Ali
Employees
10000
Address
30 Hudson Street
Floor 33
Jersey City, 07302, NJ
United States
Floor 33
Jersey City, 07302, NJ
United States
Phone
551 430 6900
Website
Instrument type
Common stock
Sector
Healthcare
Industry
Drug Manufacturers - General
Country
Italy
MIC code
XMIL